A study of COR-003 in healthy volunteers

Trial Profile

A study of COR-003 in healthy volunteers

Phase of Trial: Phase I

Latest Information Update: 10 May 2018

At a glance

  • Drugs Levoketoconazole (Primary) ; Atorvastatin; Ketoconazole
  • Indications Cushing syndrome
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 10 May 2018 According to a Strongbridge Biopharma media release,Presented results from an in vitro study of levoketoconazole, the active ingredient in RECORLEV, at ENDO 2018, the Annual Meeting of the Endocrine Society
    • 06 Apr 2016 New trial record
    • 04 Apr 2016 According to a Strongbridge Biopharma media release, results from this study were presented at the Endocrine Society's 2016 Annual Meeting and Expo.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top